Publications by authors named "C Dossier"

Claim this Profile
O
Obinutuzumab versus Rituximab to maintain remission in children with steroid-dependent and frequently relapsing nephrotic syndrome: the OBIRINS study protocol, a double-blind randomised controlled trial.
Claire Dossier, Anne-Laure Sellier-Leclerc, Thomas Simon, Cyrielle Parmentier, Olivia Boyer

BMJ Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient pseudohypoaldosteronism type I in infants with urinary tract infections and/or uropathy: insights from a French multicenter cohort.
Inès Bernhard, Claire Dossier, Laura Bianchi, Cyrielle Parmentier, Tim Ulinski

Eur J Pediatr· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obinutuzumab as a therapeutic option for SDNS children resistant to rituximab with anti-RTX antibodies.
Cyrielle Parmentier, Anne-Lise Mary, Antoine Diep, Julien Hogan, Tim Ulinski, Claire Dossier

Pediatr Nephrol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence supporting the use of anti-CD20 as first-line steroid-sparing agent in childhood nephrotic syndrome.
Claire Dossier, Julien Hogan

Kidney Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura.
Bérangère S Joly, Adrien Joseph, Raïda Bouzid, Pierre Boisseau, Thérésa Kwon, Claire Dossier

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis